| |
| |
|
| Insider
Information: |
Johnson & Johnson Development Corp Et Al |
| Relationship: |
10% Owner |
| City: |
New Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
10,136,639 |
|
|
Indirect Shares
|
43,524,732 |
|
|
| Direct
Value |
$68,514,128 |
|
|
|
Indirect Value
|
$363,303,748 |
|
|
| Total
Shares |
53,661,371 |
|
|
| Total
Value |
$431,817,876 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -31.6%
|
-36.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunicon Corp |
IMMCQ |
10% Owner |
|
0 |
2004-06-10 |
1,771,571 |
Premium* |
|
|
Universal Biosensors Inc |
UVBIF |
10% Owner |
|
0 |
2011-09-08 |
15,749,937 |
Premium* |
|
|
Tengion Inc |
TNGN |
10% Owner |
2010-04-14 |
0 |
2010-04-14 |
1,194,654 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2014-02-10 |
0 |
2014-03-12 |
1,392,094 |
Premium* |
|
|
Neurogene |
NGNE |
10% Owner |
2014-03-12 |
0 |
2015-08-11 |
100,000 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-01 |
0 |
2014-05-01 |
1,750,292 |
Premium* |
|
|
Minerva Neurosciences, Inc. |
NERV |
10% Owner |
|
0 |
2017-08-29 |
0 |
Premium* |
|
|
Nevro Corp |
NVRO |
10% Owner |
2014-11-12 |
0 |
2015-06-08 |
2,066,740 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2017-11-20 |
0 |
Premium* |
|
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
2016-08-16 |
0 |
2016-08-16 |
2,449,183 |
Premium* |
|
|
Inspire Medical Systems Inc |
INSP |
10% Owner |
2018-05-07 |
0 |
2018-05-07 |
235,251 |
Premium* |
|
|
Provention Bio Inc |
PRVB |
10% Owner |
2018-07-19 |
0 |
2018-07-19 |
2,400,000 |
Premium* |
|
|
Fusion Pharmaceuticals Inc. |
FUSN |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
3,670,516 |
Premium* |
|
|
Cvrx, Inc. |
CVRX |
|
2023-09-15 |
3,495,575 |
2024-02-29 |
4,103,430 |
Premium* |
|
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2023-09-15 |
6,641,064 |
2022-11-09 |
6,641,064 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CVRX |
Cvrx, Inc. |
|
– – • |
2024-02-29 |
4 |
OE |
$0.24 |
$2,792 |
I/I |
3,855 |
4,103,430 |
0 |
- |
|
| CVRX |
Cvrx, Inc. |
|
– – • |
2024-02-16 |
4 |
S |
$25.81 |
$96,142 |
I/I |
(3,725) |
4,099,575 |
0 |
% |
|
| CVRX |
Cvrx, Inc. |
|
– – • |
2024-02-16 |
4 |
OE |
$0.16 |
$96,021 |
I/I |
607,725 |
4,103,300 |
0 |
- |
|
| MGTX |
Meiragtx Holdings Plc |
10% Owner |
– – • |
2023-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,641,064 |
|
% |
|
| CVRX |
Cvrx, Inc. |
10% Owner |
– – • |
2023-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,495,575 |
|
% |
|
| CVRX |
Cvrx, Inc. |
10% Owner |
– – • |
2023-09-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,495,575) |
0 |
0 |
- |
|
| MGTX |
Meiragtx Holdings Plc |
10% Owner |
– – • |
2023-09-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,641,064) |
0 |
0 |
- |
|
| MGTX |
Meiragtx Holdings Plc |
10% Owner |
– – • |
2022-11-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,641,064 |
|
% |
|
| CVRX |
Cvrx, Inc. |
10% Owner |
– – • |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,495,575 |
3,495,575 |
0 |
- |
|
| FUSN |
Fusion Pharmaceuticals In... |
10% Owner |
– – • |
2020-06-30 |
4 |
B |
$17.00 |
$12,325,000 |
I/I |
725,000 |
3,670,516 |
1.5 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
10% Owner |
– – • |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,945,516 |
2,945,516 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
10% Owner |
– – • |
2018-07-19 |
4 |
A |
$0.00 |
$0 |
I/I |
2,400,000 |
2,400,000 |
0 |
- |
|
| INSP |
Inspire Medical Systems I... |
10% Owner |
– – • |
2018-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
235,251 |
235,251 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2017-11-20 |
4 |
S |
$2.75 |
$50,510,202 |
I/I |
(18,367,346) |
0 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2017-08-29 |
4 |
D |
$0.00 |
$389 |
I/I |
(3,892,256) |
0 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2016-08-16 |
4 |
B |
$12.00 |
$6,999,996 |
I/I |
583,333 |
2,449,183 |
1.5 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2016-08-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,865,850 |
1,865,850 |
0 |
- |
|
| NGNE |
Neurogene |
10% Owner |
– – • |
2015-08-11 |
4 |
S |
$20.74 |
$26,617,011 |
I/I |
(1,283,366) |
100,000 |
0 |
- |
|
| NGNE |
Neurogene |
10% Owner |
– – • |
2015-08-10 |
4 |
S |
$31.66 |
$7,327,865 |
I/I |
(231,455) |
1,383,366 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2015-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,367,346 |
|
- |
|
| NVRO |
Nevro Corp |
10% Owner |
– – • |
2015-06-08 |
5 |
S |
$48.00 |
$48,492,720 |
I/I |
(1,010,265) |
2,066,740 |
0 |
- |
|
| NVRO |
Nevro Corp |
10% Owner |
– – • |
2015-06-08 |
4 |
S |
$47.94 |
$48,432,104 |
I/I |
(1,010,265) |
2,066,740 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-03-18 |
5 |
B |
$4.93 |
$2,996,962 |
I/I |
607,903 |
3,892,256 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
10% Owner |
– – • |
2015-03-13 |
4 |
B |
$4.81 |
$2,924,013 |
I/I |
607,903 |
4,500,159 |
1.5 |
- |
|
| NGNE |
Neurogene |
10% Owner |
– – • |
2014-12-17 |
4 |
S |
$7.58 |
$12,075 |
I/I |
(1,593) |
1,342,094 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
